中
EN
Team
Portfolio
Insights
Newsroom
About Us
Newsroom
Discover our latest news, recognitions and awards.
All
ESG Spotlight
Qiming News
Portfolio News
All
ESG Spotlight
Qiming News
Portfolio News
11/2024
Portfolio News
MSD Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines
10/2024
Portfolio News
The gene therapy for hemophilia B developed by Belief BioMed has received Advanced Therapy Medicinal Product Designation from the EMA
Portfolio News
Qiming Venture Partners Celebrates WeRide's IPO on Nasdaq
Portfolio News
WeRide Unveils New Production Robotaxi GXR, Leveraging 1,800 Days of Operations
Portfolio News
Qiming Venture Partners' Portfolio Company Qiniu Cloud Successfully Lists on HKEX Main Board
09/2024
Portfolio News
Belief BioMed and AskBio, Subsidiary of Bayer, Announced Global Collaboration to Address Unmet Medical Needs with World-Class Gene Therapies
Portfolio News
Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI
Portfolio News
Hydrogen and hydrogen derivatives-fueled gas turbine company Marvel-Tech completed hundreds of millions of RMB Pre-Series B financing round, led by Qiming Venture Partners
03/2024
Portfolio News
Insilico Medicine's Study Published in Nature Biotechnology: First Novel TNIK Inhibitors for Fibrotic Diseases Discovered and Designed Using Generative AI
01/2024
Portfolio News
SUPERMAG Raises Over RMB 100 Million in Series A Financing
12/2023
Portfolio News
Qiming Venture Partners' Portfolio Company UBTech Listed on Hong Kong Stock Exchange
Portfolio News
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck
11/2023
Portfolio News
Clinical Proteomics Startup Complete Omics Inc. Successfully Completes Series A Financing, Exclusively Invested by Qiming Venture Partners
09/2023
Portfolio News
Qiming Venture Partners' Portfolio Company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange
08/2023
Portfolio News
Epigenic Therapeutics Announces $32M in Series A Funding
05/2023
Portfolio News
LTZ Announces over $10 Million Pre-A+ Financing led by Qiming Venture Partners
04/2023
Portfolio News
Zai Lab and MediLink Therapeutics Announced Strategic Partnership for a Next Generation Antibody-Drug Conjugate Program in Oncology
Portfolio News
Qiming Venture Partners' portfolio company MedSci successfully listed on HKEX main board
Portfolio News
Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901
03/2023
Portfolio News
Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq
Portfolio News
World's First Quadrivalent COVID-19 Vaccine Developed by SinocellTech is Approved for Emergency Use in China
Portfolio News
Qiming Venture Partners led two consecutive funding rounds in next-generation precision medicine company Allorion Therapeutics
Portfolio News
Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing
Portfolio News
TandemAI Raises $35 Million in Series A Financing Led by Qiming Venture Partners
02/2023
Portfolio News
Qiming Venture Partners' Portfolio Company LanzaTech Lists on Nasdaq
Portfolio News
Qiming Venture Partners Celebrates Hesai Technology's IPO on Nasdaq
Portfolio News
Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq
01/2023
Portfolio News
China's Leading Adult Interest Learning Service Provider QuantaSing Group Limited Successfully Listed on Nasdaq
12/2022
Portfolio News
SinocellTech's Recombinant Protein COVID-19 Vaccine SCTV01C Approved for Emergency Use in China
Portfolio News
CanSinoBIO's Convidecia Air™ at a Glance
11/2022
Portfolio News
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
10/2022
Portfolio News
CANbridge Announced Encouraging Development in Maralixibat in Rare Liver Disease
Portfolio News
The Case Report of Belief BioMed’s Hemophilia B Gene Therapy Drug Candidate BBM-H901 Published in The New England Journal of Medicine
Portfolio News
CanSinoBIO Celebrates the Rollout of Inhaled Vaccine Convidecia Air™ in Shanghai
Portfolio News
OriCell's GPRC5D CAR-T Received Orphan Drug Designation from FDA
Portfolio News
WeRide and Hyundai Plan to Fuel Self-driving with Hydrogen in China
Portfolio News
Abbisko Obtained Phase III Clinical Trial Approval for ABSK021 from CDE of NMPA
Portfolio News
TigerGraph Announced Commitment to Support openCypher in GSQL
Portfolio News
Qiming Venture Partners' portfolio Transwarp successfully lists on STAR Market
Portfolio News
AmoyDx and BeiGene Announced Strategic Cooperation on HER2 Companion Diagnostics
Portfolio News
CANbridge in Oral Presentation at ESGCT 29th Annual Congress
Portfolio News
Jacobio Pharma Announced a Clinical Trial Collaboration Agreement with Merck
Portfolio News
Antengene Announced Upcoming Presentations at SITC 2022
Portfolio News
Schrödinger Forged a Drug Design Collaboration with Eli Lilly
Portfolio News
Ark Biopharmaceutical Presented Positive Results at 12th International RSV Symposium
Portfolio News
CanSinoBIO to Present Latest Data at the World Vaccine Congress Europe 2022
Portfolio News
dMed-Clinipace Announced Corporate Name Change to Caidya
09/2022
Portfolio News
Zai Lab and Seagen Announced Regional Strategic Collaboration and License Agreement
Portfolio News
OriCell Therapeutics Receives Implied License from NMPA for Ori-C101 IND Application
Portfolio News
Surgical Robot Platform Company Koutech Nets Hundreds of Mns of RMB in Series A Round
Portfolio News
Insilico Medicine Clinches an Award at the HKB Technology Excellence Awards
Portfolio News
Antengene Announces ATG-101 Granted Orphan Drug Designation by the U.S. FDA
Portfolio News
Naked Eye 3D Microscope First Presented at ESE by Bondent Group
Portfolio News
Roborock Ranks First among Robot Vacuum Makers Globally in Terms of Sales Volume
Portfolio News
CanSinoBIO's Xuefeng Yu Talked Exclusively with Bloomberg on the New Convidecia Air™
Portfolio News
Insta360 Announced 360 Action Cam X3 That Makes Magic Out of the Action
Portfolio News
Genor Biopharma's GB261 Phase I/II Clinical Trial is Officially Launched in China
Portfolio News
Structure Therapeutics’ Raymond Stevens and Zai Lab’s Samantha Du Included in 2022 PharmaVoice 100 List
Portfolio News
Jacobio Receives CDE Approval for JAB-21822's Phase II Pivotal Study in China
Portfolio News
SinocellTech Receives First NMPA Approval for A Homegrown Anti-CD20 Mab
Pages
1
2
3
4
5
6
›
»
Team
Portfolio
Insights
Newsroom
About Us
Careers
Contact Us
Legal